IMIS | Flanders Marine Institute
 

Flanders Marine Institute

Platform for marine research

IMIS

Publications | Institutes | Persons | Datasets | Projects | Maps
[ report an error in this record ]basket (0): add | show Printer-friendly version

Flumiquil® in fish therapy
Boulanger, P.; Collas, R. (1989). Flumiquil® in fish therapy, in: De Pauw, N. et al. (Ed.) Aquaculture: a biotechnology in progress: volume 1. pp. 929-932
In: De Pauw, N. et al. (Ed.) (1989). Aquaculture: a biotechnology in progress: volume 1. European Aquaculture Society: Bredene, Belgium. ISBN 90-71625-03-6. 1-592 pp., more

Available in Authors 
Document type: Conference paper

Keyword
    Marine

Authors  Top 
  • Boulanger, P.
  • Collas, R.

Abstract
    The active ingredient of Flumiquil® is a fluorinated quinolone, invented by Riker/3M, and very active against Aeromonas, Yersinia, Vibrio, Edwardiella, Pasteurella at inhibitory concentrations of less than 1ug.ml-1. In fish, maximum serum levels are reached 1 and 2h after administration either by bath or by medicated feed. The 3% Flumiquil® suspension can also be administered by intramuscular or intraperitoneal route. In feed, the dosage of 12mg of active ingredient per kg of fish per day during 6 days is recommended. During the treatment period the levels are higher than 1.5g.g-1 in the tissues of the muscle and gills, and 3.2g.g-1 in those of the liver. The efficiency of Flumiquil® treatments against furunculosis, red mouth disease, and Vibriosis is well-known in France since 1980, and also in Europe and Southeast Asia. Many experimental trials conducted in fresh- and seawater indicated a very interesting protection. In contrast to the majority of antibiotics which have become less efficient due to polyresistant microorganisms, the activity of this synthetic antibacterial remains constant. Furthermore it is tolerated quite well even at doses five times the therapeutic dosage administered during 15 days. At the end of the Flumiquil® treatment, the very rapid excretion of the product and its metabolites ensure complete safety for the consumer, as far as the withdrawal period of 48h is respected.

All data in IMIS is subject to the VLIZ privacy policy Top | Authors